BioWorld MedTech

Jan. 13, 2016

J.P. Morgan Healthcare Conference 2016: Medtronic to return $5 billion of freed cash to shareholders

SAN FRANCISCO — As Medtronic plc (Dublin) approaches the anniversary of its blockbuster Covidien deal, which closed a year ago this month, the company is making strides to prove the $42.9 billion acquisition is paying off. Read More

J.P. Morgan Healthcare Conference 2016: Heartware suffers more heartache over MVAD, trial in limbo after thrombus events

Inside the Beltway: Califf breezes through Senate hearing for top job at the FDA

Company accused of lowering evidence bar: PDAC once again votes to recommend Probuphine implant

Silimed issues still not resolved: Sientra's new CEO updates physicians over crisis with Brazilian operations

Daily M&A: Smith & Nephew acquires BST-Cargel assets from Piramal Healthcare

Financings: Accuray closes $70M straight debt agreements with Cerberus

Patent Watch: Entac gets patent for technology to predict gastrointestinal impairment

World in Review: Polaris using DNAnexus for clinical omics

People in Places

product briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...